Table 2

Clinical and angiographic outcomes of the TRACK Registry versus TREVO2, AHA/ASA and non-AHA/ASA sub-cohorts

TRACK (n=629)
N (%)
TREVO2
(n=88) N(%)
p Value TRACK versus TREVO2*TRACK-AHA/ASA (n=157) N (%)*TRACK-non-AHA/ASA
(n=450)
N (%)
*p Value
AHA/ASA versus non-AHA/ASA
Clinical outcome
 mRS ≤2 at 90 days277 (47.9)34 (40)0.275 (51.4)193 (46.7)
Anterior circulation only: 158/333 (47.5%)
0.34
0.49
 NIHSS at discharge, mean (SD)17.4 (6.7)NANA11.3 (11.3)11.3 (11.1)1.00
NIHSS at 90 days, mean (SD)18.1 (18.7)NANA13.7 (16.6)19.9 (19.3)
Anterior circulation only: 18.9 (19)
0.04
0.1
Mortality at 90 days106 (19.8)29 (33)0.0119 (14.1)85 (22.2)
Anterior circulation only: 59 (19.3)
0.05
0.22
sICH44 (7.1)4 (4.5)0.48 (5.2)35 (8.0)0.28
Angiographic outcomes
 TIMI ≥2564 (89.7)NANA141 (89.8)400 (89.6)1.0
 TICI ≥2a584 (92.8)73 (85)0.0004146 (93.0)415 (92.9)1.0
 TICI ≥2b505 (80.3)60 (68)*0.005128 (81.5)360 (80.4)0.81
 TICI 2a79 (12.6)19 (22)*0.00419 (12.1)60 (12.7)0.89
 TICI 2b225 (35.8)48 (54)*0.00145 (28.7)180 (38.1)0.03
 TICI 3280 (44.5)12 (14)*<0.0582 (52.2)198 (41.9)0.03
 Distal embolization112 (23.0)NANA24 (19.4)81 (23.7)0.38
 Embolization into new territory20 (4.5)NANA10 (8.3)9 (2.9)0.042
 No of passes, mean (SD)1.9 (1.2)2.4 (1.4)0.0022.0 (1.1)1.9 (1.2)0.40
 1272 (45.6)NANA61 (41.2)201 (47.1)0.22
 2167 (28.2)NANA44 (29.7)123 (27.5)0.92
 3112 (18.8)NANA34 (23.0)78 (17.4)0.23
 >345 (7.5)NANA6 (4.1)36 (8.0)0.10
 Use of rescue therapy133 (21.5)16 (18)0.4835 (22.9)93 (21.0)0.65
 Type of rescue therapy (65/133)
 Solitaire29 (44.6)
 IA-tPA28 (43.1)
 Aspiration41 (63.1)
 Intracranial angioplasty15 (23.1)
 Fluoroscopic time (min)32.3 (22.9)NANA31.9 (21.2)32.8 (23.8)0.35
 Time of puncture to revascularization or end of procedure (min), mean (SD)78.8 (49.6)NANA77.1 (46.8)79.2 (48.9)0.64
  • *Core laboratory adjudicated.

  • Bold type indicates statistical significance.

  • AHA, American Heart Association; ASA, American Stroke Association, mRS, modified Rankin Scale; NIHSS, National Institutes of Health Stroke Scale; sICH, symptomatic intracranial hemorrhage; TICI, Thrombolysis In Cerebral Infarction; tPA, tissue plasminogen activator.